Triptolide T10 enhances AAV-mediated gene transfer in mice striatum

Neuroscience Letters

Volumn 479, Issue 3, 2010, Pages 187-191

  Ren, Xinmiao ^a   Zhang, Ting ^a   Hu, Jing ^a   Ding, Wei ^a   Wang, Xiaomin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

AAV; Gene therapy; Parkinson's disease; Triptolide

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE; TRIPTOLIDE; ANTIINFLAMMATORY AGENT; DITERPENE; ENHANCED GREEN FLUORESCENT PROTEIN; EPOXIDE; GREEN FLUORESCENT PROTEIN; HERBACEOUS AGENT; NEUROPROTECTIVE AGENT; PHENANTHRENE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHAVIOR CHANGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOTOXICITY; DEGENERATIVE DISEASE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MALE; MOTOR PERFORMANCE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TRIPTERYGIUM; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELL SURVIVAL; DEPENDOPARVOVIRUS; DRUG EFFECTS; GENE TRANSFER; GENETICS; METABOLISM; TRANSGENE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CELL SURVIVAL; CORPUS STRIATUM; DEPENDOVIRUS; DITERPENES; DRUGS, CHINESE HERBAL; EPOXY COMPOUNDS; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LUCIFERASES; MALE; MICE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; PHENANTHRENES; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 77954142024     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.046     Document Type: Article

References (16)

1. Ding W., Zhang L., Yan Z., Engelhardt J.F. Intracellular trafficking of adeno-associated viral vectors. Gene Ther. 2005, 12:873-880.
2. Doroudchi M.M., Liauw J., Heaton K., Zhen Z., Forsayeth J.R. Adeno-associated virus-mediated gene transfer of human aromatic l-amino acid decarboxylase protects mixed striatal primary cultures from l-DOPA toxicity. J. Neurochem. 2005, 93:634-640.
3. Eberling J.L., Jagust W.J., Christine C.W., Starr P., Larson P., Bankiewicz K.S., Aminoff M.J. Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 2008, 70:1980-1983.
4. Gao G., Vandenberghe L.H., Wilson J.M. New recombinant serotypes of AAV vectors. Curr. Gene Ther. 2005, 5:285-297.
5. Gong Y., Xue B., Jiao J., Jing L., Wang X. Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-kappaB and JNK in LPS-treated microglia. J. Neurochem. 2008, 107:779-788.
6. Gu W.Z., Chen R., Brandwein S., McAlpine J., Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: triptolide and tripdiolide. Int. J. Immunopharmacol. 1995, 17:351-356.
7. Kaplitt M.G, Feigin A., Tang C., Fitzsimons H.L., Mattis P., Lawlor P.A., Bland R.J., Young D., Strybing K., Eidelberg D., During M.J. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007, 369:2097-2105.
8. Lu L., Li F., Wang X. Novel anti-inflammatory and neuroprotective agents for Parkinson's disease. CNS Neurol. Disord. Drug Targets 2009, 9:232-240.
9. Mandel R.J., Manfredsson F.P., Foust K.D., Rising A., Reimsnider S., Nash K., Burger C. Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders. Mol. Ther. 2006, 13:463-483.
10. Marks W.J., Ostrem J.L., Verhagen L., Starr P.A., Larson P.S., Bakay R.A., Taylor R., Cahn-Weiner D.A., Stoessl A.J., Olanow C.W., Bartus R.T. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial. Lancet Neurol. 2008, 7:400-408.
11. Tao X, Davis L.S., Lipsky P.E. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum. 1991, 34:1274-1281.
12. Tao X., Lipsky P.E. The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum. Dis. Clin. North Am. 2000, 26:29-50. viii.
13. Van Vliet K.M., Blouin V., Brument N., Agbandje-McKenna M., Snyder R.O. The role of the adeno-associated virus capsid in gene transfer. Methods Mol. Biol. 2008, 437:51-91.
14. Zhang T., Hu J., Ding W., Wang X. Doxorubicin augments rAAV-2 transduction in rat neuronal cells. Neurochem. Int. 2009, 55:521-528.
15. Zhou H.F., Liu X.Y., Niu D.B., Li F.Q., He Q.H., Wang X.M. Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection. Neurobiol. Dis. 2005, 18:441-449.
16. Zhou H.F., Niu D.B., Xue B., Li F.Q., Liu X.Y., He Q.H., Wang X.H., Wang X.M. Triptolide inhibits TNF-alpha, IL-1 beta and NO production in primary microglial cultures. Neuroreport 2003, 14:1091-1095.